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Potassium transport plays three distinct roles in mitochondria. Volume homeostasis to prevent excess matrix swelling is a housekeeping
function that is essential for maintaining the structural integrity of the organelle. This function is mediated by the K+/H+ antiporter and was
first proposed by Peter Mitchell. Volume homeostasis to prevent excess matrix contraction is a recently discovered function that maintains a
fully expanded matrix when diffusive K+ influx declines due to membrane depolarization caused by high rates of electron transport.
Maintaining matrix volume under these conditions is important because matrix contraction inhibits electron transport and also perturbs the
structure–function of the intermembrane space (IMS). This volume regulation is mediated by the mitochondrial ATP-sensitive K+ channel
(mitoKATP). Cell signaling functions to protect the cell from ischemia-reperfusion injury and also to trigger transcription of genes required for
cell growth. This function depends on the ability of mitoKATP opening to trigger increased mitochondrial production of reactive oxygen
species (ROS). This review discusses the properties of the mitochondrial K+ cycle that help to understand the basis of these diverse effects.
D 2003 Elsevier B.V. All rights reserved.Keywords: Adenosine triphosphate; Mitochondria; Heart; ATP-sensitive potassium channel; Ion channel gating; Membrane transport; Volume regulation1. Introduction
The inner membrane of mitochondria contains the essen-
tial components of the electron transport proteins, the F1F0-
ATPase, and all of the exchange carriers that transfer
substrates between the mitochondrial matrix and the cytosol.
As uniquely recognized by Peter Mitchell, this picture is
incomplete without considering the physiology of mito-
chondria. These organelles function in a cytosolic milieu
containing Na+, K+, and Ca2 +, which are transported across
the inner membrane. The enzymes of oxidative phosphor-
ylation must be in communication with the cytosol, in order
to receive signals calling for increased ATP production.
Mitochondria also deliver signals to the cytosol, including
changes in reactive oxygen species (ROS), which activate
kinases, or cytochrome c from the intermembrane space
(IMS), leading to apoptosis. These components of mito-
chondrial physiology will be discussed in this review.
Mitochondria are structurally complex. The internal
compartment, containing the enzymes of the tricarboxylic728/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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inner membrane. External to the inner membrane is a
narrow compartment called the IMS, which, in turn, is
bounded by the outer mitochondrial membrane (OM). The
inner membrane is highly invaginated, creating internal
structures called the cristae. The region adjacent to the
OM is the peripheral inner membrane. The cristal and
peripheral inner membranes are continuous, and, although
they may have subtly different functions, they will be
treated in this review as a single inner membrane. The inner
membrane surface: volume (S/V) ratio is very high, about
500 cm2/Al of matrix volume, roughly two orders of
magnitude greater than the S/V of cells. This means that
ion traffic across the inner membrane will be very high.
Moreover, the gradients driving salt uptake are very high,
and the inner membrane is highly permeable to water. These
factors increase considerably the hazard of excessive os-
motic swelling and lysis, disrupting the vesicular structure
essential for mitochondrial function.
This review and its companion [1] will discuss three
distinct roles played by the mitochondrial K+ cycle in
mitochondrial and cell physiology: (i) to provide volume
homeostasis to prevent excessive matrix swelling; (ii) to
provide volume regulation to prevent excessive matrix
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duction for the purpose of cell signaling. This paper will
review what is known about the components of the K+ cycle
and the consequences of changes in their activities.2. The potassium cycle and chemiosmotic theory
Mitchell [2] proposed that the mitochondrial inner
membrane contains vectorially oriented electron transport
enzymes that transform the energy of substrate oxidation
into an electrogenic proton efflux. The energy is thereby
stored as a proton electrochemical potential gradient across
the inner membrane, called the protonmotive force, Dp:
Dp ¼ Dw þ ZDpH ð1Þ
where Zu (RT ln10)/F (59.2 mV at 25 jC), and Dw is the
membrane potential. In isolated mitochondria respiring in
the absence of ADP (state 2), Dw is about 190 mV and
DpH is about 0.3 units.
Chemiosmotic theory [3] is the basis for understanding
the mitochondrial K+ cycle. The very high value of Dw
required for oxidative phosphorylation is not only a pow-
erful driving force for K+ uptake, but also assures that K+
diffusion will be highly sensitive to physiological fluctua-
tions in Dw, as discussed in Section 4. Thus, dynamic
regulation of mitochondrial K+ flux in vivo is essential for
maintaining the structural and functional integrity necessary
for oxidative phosphorylation. This was clearly recognized
by Mitchell [4], who wrote:
While the introduction of the foregoing sophistication
[the chemiosmotic theory of energy coupling] solved one
problem it created another; for, the membrane potential
that would now be required to reverse the ATPase
reaction would cause the ions of opposite sign of charge
to the internal aqueous phase to leak in through the
coupling membrane. To prevent swelling and lysis, the
ion leakage would have to be balanced by extrusion of
ions against the electrical gradient. It was therefore
necessary to postulate that the coupling membraneK+
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Fig. 1. The mitochondrial potassiumcontains exchange diffusion systems. . . that strictly
couple the exchange of anions against OH ions and of
cations against H+ ions.
This hypothesis was stated long before electroneutral
cation and anion exchangers were known to exist in nature
and reveals an extraordinary depth of physiological insight.3. The mitochondrial potassium cycle—an overview
The mitochondrial K+ cycle consists of influx and efflux
pathways for K+, H+, and anions and is diagrammed in Fig.
1. Note that these ions are exchanged between the matrix
and the IMS; however, the OM does not present a barrier to
further exchange of small ions with the cytosol. Electro-
genic proton ejection by the electron transport system
generates an electrical membrane potential (1), which
drives K+ influx by diffusion (‘‘K+ leak’’) and via the
mitochondrial ATP-sensitive K+ channel (mitoKATP). This
K+ for H+ exchange will alkalinize the matrix, causing
phosphate to enter via the electroneutral Pi-H+ symporter.
Net uptake of K+ salts will be accompanied by osmotically
obligated water, resulting in matrix swelling. Excess matrix
K+ is then ejected by the K+/H+ antiporter.
Early work on the K+ cycle focused on diffusive K+
influx and K+/H+ antiport (for reviews, see Refs. [5–7]).
Because mitochondria operate at a very high Dw, there is
an inexorable influx of K+ salts and water that threatens
the integrity of the organelle. Diffusive K+ influx is too
small to have a significant effect on energy conservation,
but if it were allowed to continue unchecked, it would be
sufficient to cause matrix water content to increase by
about 15% per minute, with eventual lysis. This catas-
trophe is avoided by means of the K+/H+ antiporter,
which is regulated to sense volume changes and eject
excess K+ from the matrix [7,8].
Considering the large electrical driving force for K+
uptake, it seemed unlikely that Nature would insert a K+
channel in the inner membrane, but work from Mirono-
va’s and Diwan’s laboratories indicated that was indeed
the case [9,10]. The K+ uniporter turned out to be a~
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volume regulation. When mitochondria are synthesizing
ATP at very high rates, Dw decreases. K+ diffusion is
very sensitive to changes in Dw and the transient imbal-
ance between influx and efflux causes matrix volume to
contract to a lower steady state volume. Since matrix
contraction interferes with efficient energy transfers from
mitochondria to cytosol [1], these events occur at pre-
cisely the wrong time in relation to the cell’s energetic
needs. We propose that endogenous signals open mito-
KATP so that K
+ influx and matrix volume are maintained
in the face of a lower driving force.
It turns out that mitoKATP plays a third role in cell
physiology. When mitoKATP is opened in the resting state
of high Dw, the resulting K+ influx induces a moderate
increase in mitochondrial production of ROS [12,13]. The
increased ROS levels, in turn, activate a variety of kinases
involved in the signaling pathways of cardioprotection
against ischemia-reperfusion injury and in pathways lead-
ing to gene transcription and cell growth.
A major reason for renewed interest in the mitochon-
drial K+ cycle arose when it was found that pharmacolog-
ical agents that open mitoKATP protect the heart against
ischemia-reperfusion injury [14]. Moreover, we have found
that mitoKATP plays important roles in normal cardiac
physiology. These aspects are reviewed in the companion
paper [1].4. Potassium leak across the inner membrane
One of the four postulates of the chemiosmotic theory
is that the inner membrane must have a low diffusive
permeability to protons and ions generally; otherwise, ion
leaks would short-circuit the protonmotive batteries, and
ATP would not be synthesized [2]. Notwithstanding the
low permeability, cation leaks occur at significant rates,
and they are physiologically important: inward K+ leak
causes matrix swelling [7], and inward proton leak con-
tributes to the basal metabolic rate [15].
Diffusive transport of ions obeys the same laws that
govern transport of nonelectrolytes across thin membranes.
The rate of transport is proportional to the concentration
difference, and the proportionality constant (the permeabil-
ity coefficient) is a function of the energy barrier that must
be crossed during transport. The ionic charge adds a new
feature that derives from long-range effects of the electric
field on the local free energy of the diffusing particles. An
ion diffusing across the inner membrane of mitochondria
must traverse a single, sharp energy barrier located at the
center of the membrane, and only those ions having
sufficient energy to reach this peak will cross to the
energy well on the opposite side. The process of over-
coming this extremely unfavorable Gibbs energy of trans-
fer is clearly the rate-limiting step of ion diffusion, and net
flux will be proportional to the differential probability ofgetting to this peak from either side. This probability is
given by the Boltzmann function, exp(Dl˜p/RT ), where
Dl˜pu l˜p l˜aq is the Gibbs energy of the ion at the peak
(p) relative to its value in the aqueous energy well at the
surface of the membrane (aq). Dl˜p is the activation energy
of ion diffusion and defines the permeability coefficient.
As described in detail by Garlid et al. [16], these consid-
erations lead to the following expression for diffusive flux
of cations and hydronium ions across thin biomembranes:
J ¼ fPðC1oeu=2  C2oeu=2Þ ð2Þ
where u is the reduced voltage (zFDw/RT), C1o and C2o
are bulk aqueous concentrations, f is the surface partition
coefficient (energy well/bulk), and P is the permeability
constant, given by
PukeDl
o
p=RT ð3Þ
The factor 1/2 in the exponents of Eq. (2) arises from
the fact that the maximum energy barrier is found at the
midpoint of the membrane. This barrier splits Dw in half
when we make the customary constant field assumption.
The second term in Eq. (2) represents back-flux of
cations from the matrix and becomes negligible at the
high values of Dw maintained by respiring mitochondria.
Under these conditions, Eq. (2) reduces to a simple
exponential function of Dw:
J ¼ fPC1oeu=2 ð4Þ
Eq. (4) emphasizes the point that ion flux at high
potentials is not affected by the concentration gradient
across the membrane and also makes the important predic-
tion that all diffusing cations will experience the same rate-
limiting step. This prediction is affirmed by the flux-voltage
plots in Fig. 2, which show that TEA+ (tetraethylammonium
ion) and H+ (hydronium ion) diffusion across the mitochon-
drial inner membrane are identical with respect to their
voltage dependence.
The finding that protons and cations experience an
identical rate-limiting step is at variance with the sugges-
tion that proton leak is ‘‘anomalous’’ and that protons are
transported by a unique mechanism [17]. In fact, the
difference between proton and cation leak is only quan-
titative and largely reflects events at the membrane sur-
face, whose influence has been ignored in much of the
work on proton leaks. It must be emphasized that the
concentration terms in all flux equations for membrane
transport, including Fick’s law, apply to the energy wells
at the surface of the barrier and not to the bulk aqueous
solution [16].
Eq. (4) is relevant to conditions facing mitochondria in
vivo. When ATP production increases in response to
Fig. 2. The exponential dependence of mitochondrial cation and proton leak
on Dw. Normalized fluxes of TEA+ (.) and H+ (o) in mitochondria, J/Jo,
are plotted versus Dw as in Eq. (4). Jou f P[C]o, where [C]o is the aqueous
concentration of TEA+ or H+, respectively, and f and P are defined in the
text. Jo was obtained from the extrapolated intercept of a semilogarithmic
plot, ln( J) vs. FDw/RT. The solid line is the function eFDw/2RT, showing that
the data obey Eq. (4).
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is being drawn from the protonmotive batteries. Eq. (4)
tells us that a 10% decrease in Dw, from 190 to 170 mV,
will result in a 32% decrease in the rate of diffusive K+
uptake.5. The mitochondrial K+/H+ and Na+/H+ antiporters
5.1. Existence of the K+/H+ antiporter
The first evidence for Na+/H+ and K+/H+ antiport in
mitochondria was obtained by Mitchell and Moyle [18],
who measured swelling in NaOAc and KOAc media. These
findings were confirmed by several groups, and the view
emerged that mitochondria possess a very active Na+/H+
antiporter while K+/H+ antiport activity is either very low
or absent altogether [19–21].
In studies predating the chemiosmotic hypothesis, Gam-
ble [22] showed that 42K+/K+ exchange was respiration-
dependent, suggesting K+ cycling in mitochondria. Using
similar protocols, Brierley et al. [23–25] suggested that
42K+/K+ exchange may reflect uniport–antiport cycling of
K+ and proposed a regulated interplay between K+ uniport
and K+/H+ antiport [26]. The problem remained that K+/H+
antiport was inferred and not demonstrated directly. It was
necessary to dissect K+/H+ antiport from K+ uniport exper-
imentally in order to establish its existence.This was accomplished in our laboratory with the
demonstration that mitochondria, which retain matrix K+
when suspended in isotonic sucrose, lose K+ in hypotonic
sucrose [27]. Swelling-induced K+ efflux was reversed by
valinomycin in respiring mitochondria but not in the
absence of respiration. These and other results [8,28]
established the existence of a latent, electroneutral K+/H+
antiporter. The finding that latency of K+/H+ antiport was
released by matrix swelling provided an essential clue to
the mechanism of regulation of the carrier, as described
below. Swelling-induced K+ efflux also permitted, for the
first time, an experimental separation of K+/H+ antiport
from K+ uniport.
5.2. Mitochondria possess two cation/H+ antiporters
Prior to 1982, it was generally believed that K+/H+
exchange was mediated by a single Na+/H+ antiporter that
had a much lower affinity for K+ than for Na+. Nakashima
and Garlid [29] showed, however, that mitochondria pos-
sess two distinct cation/H+ antiporters. The Na+/H+ anti-
porter [18] is selective for Na+ and does not transport K+,
Rb+, or Cs+. The K+/H+ antiporter transports all alkali
cations (Na+, K+, Li+, Rb+ and Cs+) at similar rates, with
Km values varying between 30 and 120 mM. The Na
+/H+
antiporter exhibits a characteristic pH profile with maximal
activity at about pH 7.3 and lacks the complex regulation
exhibited by the K+/H+ antiporter. The K+/H+ antiporter,
but not the Na+/H+ antiporter, is inhibited by quinine [29].
A word about nomenclature. Both antiporters transport
Na+ under in vitro conditions. However, a consideration of
cytosolic Na+ and K+ concentrations and the respective Km
values indicates that Na+ will not undergo significant
exchange on the K+/H+ antiporter under in vivo conditions.
Therefore, its designation as the K+/H+ antiporter seems
appropriate on physiological grounds.
Garlid [30] has suggested that the plasmalemma may
contain modified versions of both mitochondrial Na+/H+
antiporters. The mitochondrial Na+/H+ antiporter resembles
the renal tubular Na+/H+ antiporter [31] in its discrimina-
tion against K+ and its competitive inhibition by Li+ [32].
The mitochondrial K+/H+ antiporter resembles a cardiac
sarcolemmal Na+–K+/H+ antiporter that transports all al-
kali cations, including Na+ and K+, and is inhibited by
dicyclohexylcarbodiimide (DCCD) and amphiphilic amines
[33,34]. The latter class of antiporter would tend to
catalyze Na+/K+ exchange in cells and dissipate the effects
of the Na+, K+-ATPase. A sound design principle would be
followed if the cell, like mitochondria, were to regulate
volume by governing a passive backflow process rather
than an active transport process.
5.3. Regulation of the mitochondrial K+/H+ antiporter
We showed in a series of papers that the mitochon-
drial K+/H+ antiporter is reversibly inhibited by Mg2+,
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inhibited by DCCD.
5.3.1. Regulation of the K+/H+ antiporter by matrix
Mg2+—the carrier brake mechanism
To explain activation of the K+/H+ antiporter by matrix
swelling, we proposed that a matrix solute acts as a
reversible inhibitor of the antiporter and that swelling
reduces inhibitor concentration by dilution. This mecha-
nism was consistent with the finding that activation of K+/
H+ antiport was independent of the cause of matrix swell-
ing [8,27,28].
A strong clue to the identity of this inhibitor came from
the dependence of swelling-induced K+ efflux on matrix
anion composition. Anions that form complexes with
divalent cations (citrate, phosphate) stimulated electroneu-
tral K+ efflux, while anions with poor chelating ability
(acetate, succinate, malate) retarded it [8]. We concluded
that the K+/H+ antiporter was regulated by matrix divalent
cations, and we subsequently showed that Mg2+ ion is the
physiological inhibitor, acting from the matrix side of the
antiporter [29,35–40]. Inhibition of K+/H+ antiport by
divalent cations follows the sequence Mn2+ < Ca2+ <
Mg2+ < Sr2+ in both rat heart and rat liver mitochondria.
The Ki for Mg
2+ inhibition is 200–400 AM in both heart
and liver [7], a result that was confirmed with the recon-
stituted K+/H+ antiporter [39].
The Mg2+ Carrier Brake Hypothesis states that the K+/H+
antiporter is under continuous partial inhibition by Mg2+ ions
and that variations in matrix Mg2+ activity are one means of
regulating matrix volume in vivo. The most important
quality of this mechanism is its sensitivity to changes in
matrix volume. Swelling in vivo is caused by net uptake of
salts, and the anions of these salts will include citrate,
phosphate and other anions that form complexes with
Mg2+. Small fluctuations in free anion content must neces-
sarily result in changes in free matrix [Mg2+], since Mg2+
content is relatively stable. In the steady state, the system will
be poised so that the rate of K+/H+ antiport precisely equals
the rate of electrophoretic K+ uniport. By attuning K+ efflux
to K+ uptake in this manner, ‘‘the Mg2+ carrier brake
prevents excessive futile cycling of K+ and minimizes the
energetic cost of doing business in a high potassium envi-
ronment’’ [8]. This hypothesis also explains the apparent
absence of K+/H+ antiport from freshly isolated mitochon-
dria: as K+ and anions are lost to the K+-free medium used
during the isolation procedure, matrix [Mg2+] rises to levels
at which the antiporter is fully inhibited. Indeed, it is this
process which determines the matrix volume of isolated
mitochondria; they would lose all their K+ salts without
Mg2+ inhibition of the K+/H+ antiporter.
5.3.2. Allosteric regulation of the K+/H+ antiporter by
matrix protons
The K+/H+ antiporter is also inhibited by matrix protons
[40]. This inhibition is allosteric and additive with thecompetition that occurs between H+ and K+ for the transport
site. As a consequence, K+/H+ antiport increases with
alkaline pH and reaches a maximum at pH 8.3 [29,41].
Proton regulation of the K+/H+ antiporter may be important
in heart mitochondria, which lack significant citrate trans-
port activity.
5.3.3. Regulation of the K+/H+ antiporter by matrix volume
Increased matrix volume itself activates K+/H+ antiport,
even when matrix Mg2+ is depleted [41–43]. The mecha-
nism of this effect is unknown. It may be due to confor-
mational changes induced by membrane stretching [42], or
the allosteric site may interact with other matrix solutes in
the nonphysiological case of very low [Mg2+] and [H+].
5.3.4. Reversible inhibition of the K+/H+ antiporter by
amphiphilic amines
A wide variety of amphiphilic amines were found to
inhibit the K+/H+ antiporter, including phenothiazines,
antidepressants, antihistamines, antiarrhythmics, and local
anesthetics [43,44]. Most agents inhibited in the 50 AM
range. This inhibition is not due to interaction with a h-
receptor-like site, because D and L isomers of propranolol
were found to have identical effects. Quinine and quina-
crine inhibit the K+/H+ antiporter of liver mitochondria
with Hill coefficients of 1.0 and Ki values at pH 7.8 of 27
and 6 AM, respectively [37]. The discovery of these
pharmacological inhibitors of K+/H+ antiport [29] proved
to be very useful for the study of cation/proton antiport in
mitochondria, because it enabled the demonstration for the
first time that mitochondria contain two different Na+/H+
antiporters [29].
5.3.5. Irreversible inhibition of the K+/H+ antiporter by
DCCD
DCCD is a non-selective probe of ion transport proteins
[45] which reacts irreversibly with carboxylic groups that
are buried within the hydrophobic core of the membrane.
We showed that DCCD inhibits the K+/H+ antiporter
irreversibly and completely [46]. We subsequently made
the interesting observation that, although Rb+/H+ exchange
was completely inhibited, Rb+/Rb+ exchange was only
partially inhibited by DCCD [39].
DCCD was found to possess the useful property that it
only inhibits the active conformation of the K+/H+ antiporter.
Thus, K+/H+ antiport is protected from DCCD inhibition by
quinine, matrix Mg2+, and matrix acidity [37,46,47]. This
property was ideally suited to protocols designed to identify
the protein by DCCD radiolabeling, and the K+/H+ antiporter
was identified as an 82 kDa protein in rat heart, beef heart,
and hamster brown adipose tissue mitochondria [38,46].
DCCD labeled submitochondrial particles, confirming that
the protein resides in the inner membrane [47]. The kinetics
of [14C] DCCD binding to the 82 kDa protein are in good
agreement with inhibitory kinetics [47], and the amount of
radiolabeled 82 kDa band yields an estimate of 7–8 pmol of
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protein. Assuming a maximal activity at 25 jC of 300 nmol/
mg min, the turnover number of the K+/H+ antiporter is about
700 per second [37].
5.4. Purification and reconstitution of the K+/H+ antiporter
The K+/H+ antiporter was extracted from mitochondrial
membranes using Triton X-100 and reconstituted into lip-
osomes [39]. This preparation exhibited electroneutral
86Rb+ transport that was reversibly inhibited by Mg2+ and
quinine. We then introduced a fluorescence assay for
liposomal K+ transport, using the K+-sensitive probe PBFI,
which was far superior to the radioisotope method [48,49].
The 82 kDa K+/H+ antiporter was purified to apparent
homogeneity on SDS-PAGE, using a multistep protocol.
The purified protein catalyzed electroneutral K+/H+ antiport
that was inhibited by DCCD, Mg2+, and timolol [50]. We
subsequently learned, however, that the 82 kDa band
contains a subunit of ubiquinone reductase in addition to
the K+/H+ antiporter (unpublished results).
5.5. The molecular identity of the mitochondrial Na+/H+
and K+/H+ antiporters
The yeast mitochondrial Na+/H+ antiporter was identi-
fied as NHA2 [51]. Isolated yeast mitochondria were
assayed for 22Na+ uptake from acetate medium. Flux was
inhibited by benzamil, an inhibitor of the mitochondrial
Na+/H+ antiporter [52], and no flux was observed in
mitochondria from yeast lacking the NHA2 gene. Although
this functional characterization is very limited, it is consis-
tent with identification of NHA2 as a mitochondrial Na+/H+
antiporter. Our laboratory had shown that yeast mitochon-
dria lack the Na+-specific Na+/H+ antiporter [53]. However,
there is no real conflict between these results, because our
light scattering assay would not have been able to detect
the very low rates of 22Na+ uptake by NHA2 (1 nmol/mg/
min) reported by Numata et al. [51].
Human NHE6 was obtained based on its strong se-
quence similarities to yeast NHA2 [51]. Seven mammalian
Na+/H+ antiporter isoforms (NHE1 to NHE7) have so far
been identified [54,55]. Of these, only NHE6 appears to be
localized to mitochondria. NHE6 contains a putative mito-
chondrial inner membrane targeting signal; dual labeling
experiments indicate mitochondrial localization; and it was
found to distribute in all tissues examined. NHE6 migrates
on SDS-PAGE with a molecular weight of about 65 kDa,
which is also consistent with our identification of the
mitochondrial Na+/H+ antiporter as a 59 kDa protein [56].
Thus, the data are consistent with identification of NHE6 as
the mitochondrial Na+-specific Na+/H+ antiporter.
NHE7 [57] is not a mitochondrial protein, but its
properties may be relevant to future molecular identifica-
tion of the K+/H+ antiporter. NHE7 is localized to the Golgi
and has no mitochondrial targeting signal. Partial charac-terization indicates that it is a non-specific (Na+, K+)/H+
antiporter that transports Na+, Li+, K+, and Rb+ and is
inhibited by quinine. Moreover, its molecular weight is in
the expected range for the 82 kDa mitochondrial K+/H+
antiporter. NHE7 appears to be similar to the K+/H+
antiporters of mitochondria [7] and plasma membrane
[33,34], whose molecular identities remain unknown.6. The mitochondrial ATP-sensitive K+ channel
The existence of a specific K+ uniport pathway was
difficult to establish in isolated mitochondria, due to the
coexistence of a considerable parallel K+ leak pathway.
Accordingly, two laboratories undertook to reconstitute a
specific K+ uniporter, and this was achieved by Mironova
et al. [9] and Diwan et al. [10]. The channel was K+-
selective; however, its regulation was not characterized.
Although activity was identified with an inner membrane
protein in the 53–57 kDa range, attempts to obtain amino
acid sequence were unsuccessful.
We began purification–reconstitution of mitoKATP in
1990 and presented the first results in 1991 [58,59]. In
the same year, Inoue et al. [60] obtained channel conduc-
tances by patch clamping fused giant mitoplasts from rat
liver mitochondria and showed that channel activity was
inhibited by ATP and glyburide, consistent with identifica-
tion as a KATP channel. In 1992, we published the results of
our reconstitution studies, which confirmed that the inner
membrane contains an ATP-dependent K+ channel [11]. We
observed in that paper that mitoKATP exhibits many prop-
erties similar to those of the plasma membrane KATP
channel (cellKATP), which is discussed in Section 6.6.1.
6.1. Detection of mitoKATP activity in isolated mitochondria
Respiring mitochondria take up K+ salts and osmotically
obligated water when suspended in K+ medium. Therefore,
matrix swelling measured using the light scattering tech-
nique [61,62] is a reasonably direct measure of K+ influx.
We have also estimated the magnitude of mitoKATP-medi-
ated K+ flux by measuring the attendant respiratory stim-
ulation in rat heart [63], and rat brain [64] mitochondria. As
is always the case in our laboratory, both protocols employ
negative controls, which consist of making the same
measurements in tetraethylammonium (TEA+) or Li+ me-
dium (in contrast to the sarcolemmal KATP, TEA
+ has no
effect on K+ flux via mitoKATP [11]).
Other techniques have not proved useful for studying
mitoKATP activity in isolated mitochondria. Thus, direct
measurement of K+ flux is not possible, because K+
concentrations are approximately the same on both sides
of the inner membrane. Changes in Dw are too small to
detect, because K+ flux through mitoKATP is very small in
magnitude [63]. In principle, it should be possible to
detect salt and water uptake by isotopic measurements
Fig. 3. ATP-dependent K+ uptake by rat heart mitochondria, with TEA+
control. Light-scattering traces from rat heart mitochondria respiring on
ascorbate/TMPD in K+ or TEA+ medium. Trace a, K+ influx in the absence
of ATP. Trace b, K+ influx in the presence of 0.2 mM ATP. Trace c, TEA+
influx in the absence of ATP. Trace d, TEA+ influx in the presence of 0.2
mM ATP. These data show that mitoKATP is K
+-selective and that ATP does
not cause volume-independent changes in the light scattering signal. From
Jaburek et al. [66].
Fig. 4. Effects of glyburide and diazoxide on mitoKATP. Light-scattering
traces from rat heart mitochondria respiring on ascorbate/TMPD in K+
medium. Trace a, K+ influx in the absence of ATP. Trace b, K+ influx in the
presence of 0.2 mM ATP. Trace c, reversal of ATP inhibition by 10 AM
diazoxide. Trace d, re-inhibition by 10 AM glyburide in the presence of 10
AM diazoxide and 0.2 mM ATP. From Jaburek et al. [66].
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matrix volume (10–15%) are similar in magnitude to the
error of measurement of matrix volume, which is the
difference between the waters of distribution of 3H2O
and 14C-sucrose [65]. This error is magnified at 25 jC
or higher temperatures.
Using the light scattering technique, we demonstrated
ATP-sensitive K+ flux in rat heart [63,66,67], rat liver [68],
and rat brain [64] mitochondria, using substrates of sites I,
II, and IV. The basic observation, contained in traces a and b
of Fig. 3, is that matrix swelling in K+ medium is inhibited
by ATP in the presence of Mg2 +. Control experiments in
K+-free medium are absolutely essential to exclude other
effects of ATP. In this experiment, TEA+ was substituted for
K+ in traces c and d of Fig. 3. Note two important aspects of
matrix swelling in TEA+ medium, which is due to diffusive
ion leak [16]: (a) it is completely unaffected by ATP, and (b)
it occurs at the same rate as K+-induced swelling in the
presence of ATP, i.e., when mitoKATP is inhibited. These
simple control experiments, reported for both rat liver [68]
and rat heart [66] mitochondria, give us confidence that the
light scattering technique is accurately reporting mitoKATP-
dependent volume changes.
Additional experiments are also necessary to convince
us that we are looking at mitoKATP-dependent processes.
The ATP-inhibited channel must be opened by KATPchannel openers and GTP, and the open channel must be
re-inhibited by a variety of channel blockers, including 5-
HD and glyburide [63,64,66,67,69–71]. An example of
these measurements is given in Fig. 4, in which the effects
of ATP, diazoxide, and glibenclamide are shown.
Das et al. [72] have repeated some of these experiments,
and Fig. 2 of this reference shows good evidence for
inhibition of K+ flux in heart and liver mitochondria by
ADP and ATP, both of which inhibit mitoKATP [11]. When
they add ATP or ADP after 4 min, they observe a slow
contraction, which we also observe. This contraction is due
to the to the temporary imbalance between K+ influx,
reduced by inhibition of mitoKATP, and K
+ efflux on the
K+/H+ antiporter.
Das et al. [72] interpretation of this data, however, is
that the effects of ADP and ATP are not due to changes in
matrix volume: ‘‘The use of light scattering to measure
changes in matrix volume and thus K+ transport is ques-
tionable since it is well established that ATP and ADP can
induce conformational changes in the mitochondria that
can lead to an increase in light scattering without any
change in matrix volume.’’ This claim cannot be supported
by any theoretical arguments. The light scattering measure-
ments use about one billion mitochondria per milliliter. The
520 nm wavelength used is of the same order as mito-
chondrial dimensions and is ideal for detecting average
volume changes [61]. It is simply impossible to detect
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Fig. 5. Assays of K+ flux via mitoKATP following purification and
reconstitution in liposomes. (Panel A) Protocol for assay of K+ flux in
liposomes. MitoKATP is reconstituted in buffer containing the K
+-sensitive
fluorescent probe, PBFI. External probe is then removed, and intra-
liposomal K+ is followed by fluorescent assay [11,49]. (Panel B) K+ flux
assay. Little K+ influx is observed in the absence of CCCP (bottom curve);
however, a rapid K+ uptake is observed in the presence of CCCP (top
curve), reflecting electrophoretic K+ flux via mitoKATP. This flux is
inhibited by ATP (in the presence of Mg2+), and the ATP-inhibited flux is
restored by the KATP channel opener, cromakalim.
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a technique.
Indeed, we have shown directly that ATP does not cause
‘‘conformational changes’’ in the light scattering signal.
Our first paper on mitoKATP activity in isolated rat liver
mitochondria, published 10 years ago, showed that swelling
was unaffected by ATP in TEA+ medium [68]. The data in
Fig. 3, published 5 years ago, shows a similar result in rat
heart mitochondria [66]. We have also examined mitochon-
drial swelling due to passive diffusion of erythritol and
malonamide [62] and found ATP to have no effect. We
routinely carry out such controls, and in hundreds of
experiments, we have never observed effects of ATP in
non-K+ media. If Das et al. [72] had carried out these
simple control experiments, they would have avoided
spurious claims about conformational change.
6.2. Purification and reconstitution of mitoKATP
Mitochondrial membrane proteins were extracted with
Triton X-100, and the extract was fractionated on a
variety of columns. We identified the fraction containing
mitoKATP by reconstitutive activity [11,49]. The partially
purified proteins were reconstituted into liposomes con-
taining the trapped K+-sensitive fluorescent probe, PBFI
(Fig. 5A), permitting quantitative measurements of K+
flux. As shown in Fig. 5B, this preparation catalyzed
electrophoretic K+ flux that was inhibited with high
affinity by ATP and glyburide. MitoKATP was highly
selective for K+ [11]. We also measured electrical activity
after reconstitution of mitoKATP in lipid bilayer mem-
branes [71]. A second technique, pioneered by Mironova
et al. [9], uses ethanol extraction of mitochondrial mem-
branes [49]. This procedure extracts mitoKIR but not
mitoSUR, presumably because mitoKIR is a more hydro-
philic protein. MitoKIR has been reconstituted into lip-
osomes and inserted into lipid bilayer membranes for
study of electrical activity [73,74].
6.3. Subunit structure of mitoKATP
The subunit structure of mitoKATP appears to be qual-
itatively similar to that of cellKATP, which are heteromul-
timers consisting of a 49–51 kDa inward-rectifying
potassium channel (KIR6.1 or KIR6.2) and a 140–180
kDa sulfonylurea receptor (SUR1, 2A, or 2B), as de-
scribed in Section 6.6. MitoKATP also consists of two
subunits—a 55 kDa mitoKIR and a 63 kDa mitoSUR (Fig.
6). MitoSUR was identified by specific, high-affinity
labeling with fluorescent BODIPY-FL-glyburide (FL-
GLY) [64], with a Kd about 13 nM [75]. Preparative
SDS-PAGE showed that only the 63 kDa protein was
labeled by FL-GLY. On the basis of its molecular size and
its biochemical similarity to plasma membrane SUR, we
predict that mitoSUR will turn out to be a half-molecule
ABC protein.Several lines of evidence show that the mitoKIR
preparation contains the K+ channel moiety of holo-
mitoKATP: (a) both active fractions contain a 55 kDa
inner membrane protein; (b) both channels are K+-selec-
tive [9,11,73]; (c) the unitary conductance of both prep-
arations is 10 pS in 100/100 mM KCl [71,73,74]; (d)
pharmacological agents that open or close mitoKIR
exhibit the same effects and K1/2 values when applied
Table 1
Nucleotide modulation of mitoKATP
Ligand Action K1/2 value
ATP (no Mg2+) no effect –
ATP ( +Mg2+) inhibit 39 AM
ADP ( +Mg2+) inhibit 280 AM
Palmitoyl CoA ( +Mg2+) inhibit 260 nM
Oleoyl CoA ( +Mg2+) inhibit 40 nM
GTP ( +ATP+Mg2+) open 7 AM
GTP ( + PCoA+Mg2+) open 232 AM
GDP ( +ATP+Mg2+) open 140 AM
UDP ( +ATP+Mg2+) open 13 AM
The values reported are primarily from Ref. [11] and Ref. [70].
Fig. 6. Purification of the mitochondrial ATP-sensitive K+ channel.
MitoKATP was first purified from brain mitochondria [64] on a DEAE-
cellulose column and eluted with 250 mM KCl (panel A, lane 1). This
fraction was further purified on an ATP-affinity column (panel B, lane 2).
The reconstitutively active fraction separates on 10% SDS-PAGE as two
protein bands of 63 kDa (mitoSUR) and 55 kDa mitoKIR).
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an inward-rectifying K+ channel [9,73].
6.4. Orientation of nucleotide regulatory sites in
mitochondria
We found that the presence of Mg2 + in the reconsti-
tution buffer causes 90% of the regulatory sites to face
inward in liposomes, while the absence of Mg2+ causes
the reverse orientation. This finding enabled us show that
the binding sites for Mg2+, nucleotides, and long-chain
CoA esters all reside on the same side of the mitoKATP
complex. Further experiments showed that these regula-
tory sites face the IMS [71].
6.5. Regulation of mitoKATP
MitoKATP is subject to a rich variety of regulation by
biochemical and pharmacological agents, some of which
interact with mitoSUR, whereas others interact with
mitoKIR.
6.5.1. Regulation of mitoKATP by nucleotides, CoA esters,
and Mg2+
Reconstituted mitoKATP is inhibited by ATP, ADP, and
long-chain CoA esters, with K1/2 values shown in Table 1.
Note that the effects of ADP and oleoyl CoA (inhibition)
are opposite to what is normally observed with cellKATP
(opening). Inhibition exhibits an absolute requirement for
Mg2+ (50 AM) or Ca2+ (50 AM) [11,70]. Because CoA
esters do not chelate Mg2+, this requirement implies thatMg2+ interacts independently with the protein. The ATP-
inhibited protein is opened by GTP, GDP, or UDP ([64,70]
and unpublished data).
6.5.2. Pharmacological blockers of mitoKATP
When mitochondria are incubated under standard con-
ditions (without addition of ATP or Mg2+), mitoKATP is
open and sensitive to ATP +Mg2+, but it is completely
insensitive to glyburide and 5-OH-decanoate (5-HD). We
recognized, however, that standard in vitro conditions are
very far removed from those that are obtained in vivo when
inhibitors are added. When mitochondria are incubated in
the presence of ATP, Mg2 +, and GTP (or a pharmacological
KATP channel opener), mitoKATP is again open, but it is now
highly sensitive to glyburide and 5-HD, with K1/2 values of
1–6 and 45–75 AM, respectively. These results show that
although different open states of mitoKATP catalyze identical
K+ fluxes, they may exhibit very different susceptibilities to
channel inhibitors [66].
6.5.3. Pharmacological openers of mitoKATP
We showed that mitoKATP is a high-affinity receptor for
K+ channel openers (KCO), including cromakalim, diazo-
xide, and two cromakalim analogues [69]. Cromakalim
opened mitoKATP with micromolar potency, and we pro-
posed that mitoKATP may be the site of action for the
cardioprotective effects of KCOs. Ongoing studies of the
pharmacology of mitoKATP reveal that all KCOs known to
act on plasma membrane KATP channels also act to open
mitoKATP (Paucek and Garlid, unpublished data).
6.5.4. Regulation via mitoKIR
A great deal has been learned about cellKATP from
studies of KIR in the absence of SUR. These studies were
made possible by the finding that removal of the C-
terminus of KIR6.2 enabled functional expression of this
channel [76]. Native mitoKIR is reconstitutively active
without truncation, and its properties have been studied
extensively by Mironova et al. [73,74,77]. Reminiscent of
findings with KIR6.2 [78], mitoKIR is inhibited by ATP
with low affinity (K1/2 = 500 AM) and without the require-
ment for Mg2 +, suggesting that the Mg2 + binding site is
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inhibition of mitoKIR noncompetitively (Mironova, Paucek
and Garlid, unpublished).
MitoKIR is insensitive to glyburide, 5-HD, and the
classical KATP channel openers, because these drugs act
via mitoSUR. However, we have recently identified a
number of other agents that block or open K+ flux through
mitoKIR. These drugs are equally effective on holo-mito-
KATP in both liposomes and intact mitochondria. One such
agent is the benzocaine derivative DEB ( p-diethlyaminoe-
thylbenzoate), which activates mitoKIR channels in bilayer
membranes [79]. We have confirmed that DEB opens both
mitoKIR and holo-mitoKATP in the reconstituted system and
in mitochondria, with K1/2 about 10 AM (Mironova, Paucek
and Garlid, unpublished). The membrane potential probe,
tetraphenylphosphonium (TPP+), is a potent inhibitor and
inhibits both mitoKIR and holo-mitoKATP in the reconsti-
tuted system and in mitochondria, with K1/2 about 50 nM
(Paucek and Garlid, unpublished data).
6.5.5. Regulation of mitoKATP in vivo
As we have seen, both mitoSUR and mitoKIR are
nucleotide-binding proteins. It must be noted that ATP
inhibits K+ flux through mitoKATP at nonphysiologically
low concentrations of ATP, and there is no evidence that
mitoKATP activity in vivo is affected by changes in ATP
concentration. For these reasons, we do not consider ATP
to be a regulator of mitoKATP in the true sense of the word.
There is strong pharmacological evidence that mitoKATP is
normally closed in vivo and can be opened by a variety of
endogenous signaling pathways that may be triggered by
Ca2+, ouabain, plasma membrane receptor ligands, and by
brief ischemia followed by reperfusion [1]. Thus, in vivo
evidence indicates that mitoKATP is opened by endogenous
signaling pathways. Given that numerous kinases are acti-
vated by these pathways, it is reasonable to speculate that
mitoKATP is regulated in vivo by phosphorylation.
6.6. A comparison of cardiac mitoKATP and cellKATP
From our first experiments, we were struck by the fact
that mitoKATP reacts with the same biochemical and phar-
macological ligands as those that regulate cellKATP. On this
basis, we predicted that molecular identification of mitoKATP
would reveal it to be a member of the KATP channel family
[80]. At the same time, mitoKATP, like most individuals in a
family, has its own unique features, and these identify it as a
distinct subtype of the family. A brief review of cellKATP
properties is included to facilitate these comparisons.
6.6.1. Plasma membrane KATP channels (cellKATP)
CellKATP were first identified as 80 pS channels by
Noma in 1983 by patch clamp in cardiac myocytes [81],
and have subsequently been found in many cell types. In
pancreatic h-cells, cellKATP regulate glucose-stimulated
insulin secretion and are the targets for sulfonylureas usedto treat type 2 diabetes [82]. In vascular smooth muscle,
they regulate vascular tone and are targets for diazoxide and
pinacidil in the treatment of hypertensive emergencies
[83,84]. In skeletal muscle, cellKATP may be activated in
fatigue [85]. In cardiac muscle, they were originally thought
to be involved in ischemic preconditioning and ischemic
protection by KCO [86,87].
CellKATP are heteromultimers of two subunits, an in-
ward-rectifying potassium channel (KIR), and a regulatory
sulfonylurea receptor (SUR). KIR6.x co-assemble with SUR
in a 4:4 complex to form an octameric channel [88–90]. An
RKR domain in the C-terminus of KIR6.x and in the sixth
intracellular loop of SUR prevents membrane expression of
either of these proteins in the absence of its partner [91].
The SURs are members of the ATP-binding cassette
(ABC) family, which also includes P-glycoprotein and
CFTR. SUR is thought to contain 17 transmembrane
domains (TMD) arranged in three groups [92–94]. The
genes encoding SUR1 and SUR2 are 70% homologous,
while SUR2A (cardiac) and 2B (smooth muscle) are splice
variants that differ only in 42 amino acids encoded by the
final exon [95]. SUR1 regulates the h-cell channel, SUR2A
the cardiac channel, and SUR2B the smooth muscle channel
[94–99].
SUR contains two separate nucleotide binding domains
(NBDs), each composed of a Walker A and B domain
separated by a linker region. Mutating the lysine in Walker
A or the aspartate in Walker B in either of the NBDs of
SUR1 causes loss of MgADP activation of the channel
[90,100]. SUR is the receptor for sulfonylureas and KCOs
[95,96,101]. By exchanging domains between SUR1 and
SUR2B, two TMDs were identified that are critical for
KCO binding. The receptor sites for KCOs and sulfony-
lures are closely associated within a specific regulatory
domain (Thr1059–Asn1320) in TMDIII of SUR1 [102,103].
KCO binding to SUR1, SUR2A and SUR2B (measured
from the effect on labeled glyburide displacement) requires
ATP, Mg2+ or Mn2+, and non-hydrolyzable ATP-analogues
do not support binding. These results suggest that KCO
binding requires a conformational change induced by ATP
hydrolysis [104–106]. Glyburide blocks both KIR6.2-
SUR1 and KIR6.2-SUR2A with high affinity, but 5-HD
does not inhibit cellKATP.
All KIR channels are tetramers, usually of identical
subunits. They have two TMDs linked by a pore loop
containing either GYG or GFG [107]. C-terminal trunca-
tions of KIR6.2 (KIR6.2DC26) permit expression and
channel measurements [76]. KATP channel openers and
sulfonylureas do not block KIR; however some drugs, such
as phentolamine [108], cibenzoline [109], and DIDS and
SITS [110,111] block KIR6.2DC26 in the absence of SUR.
Quaternary ions such as TPP+ block cellKATP [112], most
likely by acting directly on KIR.
It is thought that ATP inhibits cellKATP by interacting
with KIR6.2 and that SUR confers high affinity to this
binding [76,113]. ATP inhibition kinetics suggest that four
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consistent with this interpretation have been presented
[114,115].
An ATP-insensitive, but MgGDP-activated channel is
observed when KIR6.1 and SUR2B are coexpressed, and
this is thought to correspond to the nucleotide-activated
channels found in smooth muscle [99,116,117] and the
KATP channels in hypothalamic glucose-receptive neurons
[118]. Suzuki et al. [119] have shown that mitochondria
are immunostained with antibodies to KIR6.1. We have
examined these antibodies with the following results: (a)
they have no effect on K+ flux via reconstituted mito-
KATP; (b) they react with at least three mitochondrial
proteins; however, (c) they do not react with any protein
in the reconstitutively active purified fraction of mito-
KATP. The antibodies were raised to a 12 amino acid
fragment of KIR6.1, and it seems likely that they
recognize non-KATP proteins with homologies in a
limited domain. It is also important to note that KIR6.1
migrates in our hands as a 47–49 kDa protein on SDS-
PAGE, whereas mitoKIR migrates as a 54–55 kDa
protein.
6.6.2. MitoKATP and cellKATP—similarities and differences
After more than 10 years of study, it is abundantly clear
that mitoKATP and cellKATP are generally regulated by the
same ligands and drugs. However, mitoKATP possesses
many unique properties that identify it as a distinctive
subtype of the KATP family.
We compared mitoKATP and cellKATP purified from the
same tissue (beef heart) using identical flux/reconstitution
protocols [14,69,120]. We found that they may be
extracted and fractionated using the same protocols, but
that activities elute at widely different salt concentrations
[69]. On SDS-PAGE, mitoKIR migrates at a higher MW
than KIR6.1 or 6.2, and mitoSUR migrates at a far lower
MW than any of the plasma membrane SURs [64].
There are numerous biochemical and biophysical differ-
ences between mitoKATP and cellKATP. The conductances
of cardiac mitoKATP and cellKATP are very different—10
and 80 pS, respectively. MitoKATP is unique in its absolute
requirement for Mg2+ for ATP inhibition. MgADP and
long-chain acyl CoA esters inhibit mitoKATP [11,70], but
they open cellKATP [121].
MitoKATP is a distinct pharmacological receptor. When
cardiac mitoKATP and cellKATP were studied under identical
conditions, diazoxide was found to be 1000 times more
potent in opening mitoKATP than cellKATP and 5-HD was
found to inhibit mitoKATP but not cellKATP [14,69]. More-
over, TEA+ inhibits most KIRs of the plasma membrane,
but has no effect on mitoKATP.
Finally, we raised polyclonal antibodies to the mixture
of 55 kDa proteins in the reconstitutively active mitoKATP
fraction. These antibodies do not react with proteins in the
reconstitutively active cellKATP fraction from beef heart.
Moreover, the antibodies inhibit K+ flux through reconsti-tuted mitoKATP, but have no effect on K
+ flux through
reconstituted cellKATP (Paucek and Garlid, unpublished
data).7. The K+ cycle in yeast mitochondria
Yeast mitochondria presumably have the same need for
volume homeostasis as mammalian mitochondria, and
indeed an active K+/H+ antiporter was described by Villa-
lobo et al. [122]. Welihinda et al. [53] investigated the
regulation of this process in an effort to determine whether
yeast mitochondria contain a separate Na+-specific Na+/H+
antiporter. Na+ and K+ transport were both completely
inhibited by propranolol and quinine, and they were
inhibited to a similar extent by Mg2+, Ca2+, and DCCD.
Moreover, the pH profile of this antiport was similar to that
of the mammalian K+/H+ antiporter, with a pKi of 7.7.
These results are consistent with a single, non-specific K+/
H+ antiporter; however, the existence of a specific Na+/H+
antiporter with very low activity would not have been
detected in these studies. Increasing the K+ cycle by
increasing [K+] was found to stimulate oxidative phos-
phorylation in yeast mitochondria without uncoupling
[123].
Yeast also appear to increase mitochondrial ion perme-
ability to avoid imbalances due to excess energy conserva-
tion. This was first described by Prieto et al. [124] as a
proton-conducting pathway and subsequently as an anion
uniporter that transports Br and Cl [125], although it is
not clear how the latter pathway can uncouple in vivo. It
seems more likely to be a non-selective cation uniport
pathway, as described by Guerin et al. [126] and Manon
[127]. It has been suggested that this pathway is the yeast
counterpart of the permeability transition [128]. This path-
way is stimulated by ATP or GTP and inhibited by Pi or
ADP. Lu and Beavis [129] found that leader sequence
peptides activate a non-selective cation uniport in yeast
mitochondria. Because transport was not affected by ATP
or cyclosporin, they concluded that it does not reflect
mitoKATP or the permeability transition.8. The K+ cycle in plant mitochondria
An indication that plant mitochondria possess a very
active K+ cycle was the demonstration of very high K+/H+
antiport activity by Diolez and Moreau [130]. This was
later complemented by the demonstration, in a variety of
plant mitochondria, that a K+ uniport pathway with char-
acteristics of mitoKATP catalyzes sufficient flux to collapse
Dw [131]. K+ influx was inhibited by ATP, and this
inhibition was reversed by diazoxide or GTP. The authors
proposed a K+ cycle similar to that in Fig. 1, but differing
quantitatively in that K+ flux in plant mitochondria is
sufficient to uncouple respiration completely. Petrussa et
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found that it was opened by cyclosporin A. In recent
studies, these authors confirmed that ATP inhibition of
K+ flux was reversed by GTP and diazoxide and, in
contrast to Pastore et al. [131], found that glyburide and
5-HD inhibited the GTP-stimulated K+ flux [133].
Plant mitoKATP appears to play a major role in the in
vitro regulation of succinate dehydrogenase (SDH). It had
been known for some years that plant SDH is activated by
ATP and ADP, but the mechanism was unknown. Affourtit
et al. [134] showed that SDH is inactivated by K+ and
reactivated by nucleotides acting from the IMS, and they
hypothesize that these effects are mediated via plant
mitoKATP.Fig. 7. Osmotic behavior of rat liver mitochondria. Wm is linear and
reversible over the range shown, provided that there is no solute loss during
the measurement. b is linear and reversible over the initial range, and then
undergoes an irreversible transition when the outer membrane ruptures. Rat
liver mitochondria (0.1 mg/ml) were incubated in media containing 5 mM
Hepes, pH 7.2, 0.1 mM EGTA, 2 AM rotenone and concentrations of KCl to
obtain the osmolalities indicated. Total mitochondrial volume from light
scattering (b) and matrix water content (Wm) were measured as described in
Ref. [61].9. The effect of net K+ influx on anion influx and
matrix pH
As shown in Fig. 1, each mode of K+ flux is associated
with an equal counter-flux of protons. Electrophoretic K+
influx is electrically coupled to electrogenic H+ efflux, and
electroneutral K+ efflux is intrinsically coupled to electro-
neutral H+ influx. Consider the consequence of net K+
influx when mitoKATP is opened. The resulting increase in
matrix pH, dpHi, is related to net loss of protons from the
matrix,  dHi+, as follows:
dpHi ¼ dHþ=Bi ð5Þ
where Bi (nmol/mg pH) is the buffering capacity of the
matrix, about 25 nmol/mg [135]. If mitoKATP opening
causes a total net K+ uptake of 70 nmol/mg, then matrix
pH would increase by 2.8 units! However, the increasing
pH gradient drives uptake of phosphoric acid on the Pi
transporter, which largely mitigates the pH change. In liver
mitochondria, tricarboxylate and dicarboxylate exchange
porters are linked to each other and to the Pi transporter,
and these anions will also enter with protons. The most
rapid response will be given by the Pi transporter itself,
because of its greater capacity. This is especially true in
heart and brain, in which several of the anion exchangers
are lacking or possess low activity.
Palmieri et al. [136] showed that substrate anions that
participate in this cascade distribute across the inner
membrane so that the fully protonated acid has equal
activity in both phases, just as if they penetrated by non-
ionic diffusion. This result can be expressed as follows:
½Azi=½Azo ¼ 10zDpH ð6Þ
where z is the valency of the unprotonated anion (excel-
lent reviews of mitochondrial anion transport are found in
Refs. [137–141]).Eq. (5) may be expressed in terms of the amounts of K+
and anions taken up into the matrix:
dpHi ¼ ðdKþ  zdAÞ=Bi ð7Þ
Eq. (7) shows that matrix pH can only remain constant
if uptake of anionic equivalents equals uptake of K+. In
vivo, cytosolic anion concentrations are low, and matrix
alkalinization will always accompany net K+ uptake (the
extent of alkalinization can be estimated from simulta-
neous solution of Eqs. (6), (7), and (8)). The increase in
matrix pH secondary to mitoKATP opening may be sig-
nificant in heart, in which resting Pi levels are on the
order of 1 mM.10. The effect of changes in K+ influx on matrix and
IMS volumes
10.1. Osmotic equilibrium in mitochondria
The inner membrane is highly permeable to water [61],
which keeps mitochondria in a state of osmotic equilibrium
with its environment. As shown in Fig. 7, osmotic equilib-
Fig. 8. Correcting the isolation artifact in mitochondria volume. During
isolation, mitochondria lose K+ salts and water via the K+/H+ antiporter and
anion porters. This causes the matrix to become highly contracted relative
to its normal state in vivo. Matrix and IMS volumes can be restored to their
original values by mild osmotic swelling in hypotonic media or by respiring
in K+ salts.
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Wm (Al H2O/mg), and matrix solute content, Sm (nmol/mg)
[65]:
Wm ¼ Wa þ gmSm=/ ð8Þ
where gm is the osmotic coefficient of the internal phase
(estimated to be about 0.94) and / is the osmolality, about
300 mosM in vivo. Wa is the osmotic intercept and corre-
sponds to water that is occupied by protein hydration and is
therefore osmotically inactive [65]. It can be seen that
uptake or loss of K+ salts, causing a change in Sm, will be
accompanied by osmotically obligated water and swelling
or shrinking of the matrix.
Tedeschi and Harris [142,143] showed that changes in
matrix volume can be followed by light scattering, which is
a very important tool for studies of mitochondrial ion
transport. Most studies follow absorbance (A) of the sus-
pension, but this approach is only useful for gross irrevers-
ible changes, called high-amplitude swelling. The proper
variable is the quantity, P[1/A 1/Al], which we call b,
and which is proportional to the volume of the scattering
particle. P is the mitochondrial protein concentration in the
assay, and 1/Al is the intercept of a double reciprocal plot
relating A to protein concentration in the assay [61].
Fig. 7 contains a plot of b versus inverse osmolality, 1/
/, for rat liver mitochondria. Entirely similar results were
obtained for rat heart mitochondria [67]. We have shown
that b is fully reversible in the isosmotic range [61]. Stoner
and Sirak [144] showed that matrix swelling–contraction
in the isosmotic range (the first linear segment of the light
scattering osmotic curve) occurs at the expense of the IMS.
Thus, IMS volume varies reciprocally with matrix volume
under physiological conditions. At a certain point (occur-
ring in Fig. 7 at / = 115 mosM), b is no longer reversible.
Thus, addition of hypertonic solution to the assay causes
the matrix to contract, but b does not return to its original
value [61]. This is caused by outer membrane rupture,
which leads to the presentation of a larger scattering
surface and which, of course, is irreversible under these
conditions. We have called this the ‘‘Humpty Dumpty’’
effect [7].
The data in Fig. 7 illustrate a number of important
aspects of the light scattering technique: (a) b can be
quantitatively related to matrix water content, and the
kinetics of light scattering changes, db/dt, can be trans-
formed to solute transport rates [62]; (b) light scattering
kinetics can be measured reliably in the range after the
outer membrane has ruptured, because this part of the
light scattering curve is also linear with matrix volume
[38,62]; (c) light scattering is a very useful method for
determining the osmolality and matrix volume at which
the outer membrane ruptures; (d) given that the IMS is
very small in vivo, the measurement of matrix volume at
which outer membrane ruptures provides an estimate ofthe matrix volume that obtains in vivo; (e) it must be
emphasized that the transition point depends very strong-
ly on conditions of mitochondrial isolation. Prolonged
incubation in K+ free medium causes loss of matrix K+
salts, and the transition will occur at low osmolalities.
Isolation performed rapidly or in the presence of quinine
to inhibit the K+/H+ antiporter, will cause retention of
matrix K+ salts, and the transition will occur at higher
osmolalities.
10.2. The isolation artifact in matrix and IMS volumes
Perhaps the most important and least appreciated iso-
lation artifact of mitochondria is the excess matrix con-
traction due to loss of K+ (via K+/H+ exchange) and
anions during isolation in K+-free medium [8]. Studies
described in the companion paper [1] indicate that this
artifactual matrix contraction has profound effects on
electron transport and on the outer membrane permeability
to nucleotides. As shown diagrammatically in Fig. 8, the
changes can readily be reversed in vitro by two indepen-
dent means that are entirely equivalent. With reference to
Eq. (8), it is evident that matrix volume can be restored
either through respiration-driven uptake of K+ salts (Eq.
(9)) or by changing the osmotic strength of the medium
(Eq. (10)):
DWm ¼ DSm=/ ð9Þ
DWm ¼ SmDð1=/Þ ð10Þ
10.3. MitoKATP opening increases matrix volume
Matrix volume can be restored to near-normal (in vivo)
values by means of respiration in K+ salts, as illustrated in
Fig. 8. From this steady state, mitoKATP opening causes a
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chondria from rat heart, liver and brain, and this effect is
blocked by 5-HD [63,64]. MitoKATP opening was also
shown to regulate matrix volume during simulated ische-
mia and state 3 respiration. Addition of antimycin A to
simulate ischemia caused a 10–15% contraction in matrix
volume, and a contraction of similar magnitude was
observed following addition of ADP to trigger state 3
respiration [63]. In both cases, the contraction is due to
depolarization and decrease in diffusive K+ influx. In both
simulated ischemia and state 3 respiration, diazoxide
reversed the contraction and caused steady state volume
to return to near its original steady state levels. This effect
of diazoxide was blocked by 5-HD. It is important to
emphasize that in these conditions, opening mitoKATP
provides a parallel K+ conductance that compensates for
the lower driving force for K+ influx. It may be physio-
logically significant that the magnitude of K+ flux through
mitoKATP is so well-matched to the changes associated
with both ischemia (in the presence of ATP) and maximum
ATP production.
10.4. The kinetics of matrix volume changes
We have shown that under specific conditions, matrix
water content, Wm, depends on matrix K
+ content as
follows [65]:
Wm ¼ Wa þ 1:52Kþ=/ ð11Þ
Let Au//1.52, and vKNETu dK
+/dt (net K+ uptake).
Then
dWm=dt ¼ vKNET=A ð12Þ
where vKNET is net K
+ influx into the matrix, and A is
160–200 mM. vKNET is the sum of individual K
+ flux
pathways:
vKNET ¼ vKATP þ vKLEAK  vK=H ð13Þ
Wewill make the approximation that the sensitivity (aK/H)
of the K+/H+ antiporter to changes in matrix volume is
constant over the limited range of volumes that occur
between steady states,
dvK=H=dt ¼ aK=HdWm=dt ¼ aK=HvKNET=A ð14Þ
Of the pathways in Eq. (13), only vK/H is capable of
responding to changes in matrix volume; therefore,
dvK=H=dt ¼ dvKNET=dt; and ð15ÞdvKNET=dt ¼ aK=HvKNET=A ð16Þ
Eqs. (12) and (16) are integrated in succession to yield
DWmðtÞ ¼ ðDvKNET=aK=HÞð1 eða=AÞDtÞ ð17Þ
Eq. (17) describes the approach of matrix volume to the
new steady state in response to a sudden change in electro-
phoretic K+ uptake, such as mitoKATP opening or a drop in
Dw. The data published in Kowaltowski et al. [63] enable us
to determine how well this equation fits the experimental
results. We found in heart mitochondria at 25 jC that
DvKNET for mitoKATP opening is about 30 nmol/mg min,
based on the difference in respiration observed when mito-
KATP was open or closed. A similar comparison showed that
the difference in steady state matrix water contents in these
two states (DWm at t=l) is about 0.36 Al/mg. This allows
us to estimate aK/H at 83 mM/min, using Eq. (17) at t=l. If
we assume that Ac 180 mM, we may calculate the half-
time to achieve the new steady state from Eq. (17). This
value is about 1.5 min, which is in good agreement with the
experiments on isolated mitochondria [63].
10.5. MitoKATP opening decreases IMS volume
Electron micrographs of mitochondria in vivo indicate
that the matrix is tightly packed within the outer mem-
brane, leading to a narrow average intermembrane dis-
tance between inner and outer membranes, rIMS. Most of
the changes in matrix volume caused by mitoKATP
opening, ischemia, or the high-work state, will be
reflected in a reciprocal change in IMS volume. We can
estimate the corresponding change in rIMS from mem-
brane surface areas (SA). Inner membrane SA for isolated
rat liver mitochondria are in excellent agreement [15,145],
and Cieciura et al. [146] have provided comparative
measurements of SA per unit mitochondrial volume for
heart and liver mitochondria in situ. The values for
isolated heart mitochondrial SA were derived by assuming
that mg protein per unit volume is about the same for
heart and liver mitochondria. Liver inner and outer
membrane SA are 521 and 155 cm2/mg [145], and the
corresponding derived values for heart mitochondria are
1094 and 194 cm2/mg. From these values, we estimate
that a change in IMS volume of 0.35 Al/mg corresponds
to a change in rIMS of 32 A˚. If rIMS is normally 130 A˚,
diazoxide would reduce this to 88 A˚ if all of the volume
changes were transmitted to the IMS. Since the outer
membrane is capable of some expansion, as judged by
light scattering [61], the actual rIMS would be somewhat
greater. Conversely, ischemia or the high-work state
would decrease matrix volume and increase rIMS to about
162 A˚. Although these are rough approximations, they
suggest that physiological changes in matrix volume may
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example, the octameric mitochondrial isoform of creatine
kinase (Mi-CK), which is proposed to be the dominant
form in vivo, is cubic with a side length of 93 A˚
[147,148]. The importance of these changes in IMS
volume in relation to Mi-CK is discussed in the compan-
ion paper [1].11. Bioenergetic consequences of opening mitoKATP
It is now generally agreed that mitoKATP plays a key
role in cardioprotection against ischemia-reperfusion injury
[1,14,69]; however, there is considerable controversy over
the bioenergetic consequences of opening mitoKATP in
vivo [12]. We have discussed in previous sections that
the matrix will become more alkaline and matrix volume
will expand. Now we turn to the effects of mitoKATP
opening on respiration, Dw, and mitochondrial production
of ROS.
11.1. The effect of mitoKATP opening on respiration and Dw
We have measured the effects of ATP, ATP + diazoxide,
and ATP + diazoxide + 5-HD on respiration in both rat
heart [63] and rat brain [64] mitochondria. Based on these
studies, the magnitude of K+ flux through mitoKATP is
24–30 nmol K+/min 1 mg 1 at 25 jC in rat heart
mitochondria. Similar measurements in mitochondria uti-
lizing site I substrates by Kopustinskiene [149] yields an
implied rate of 50 nmol K+/mg/min at 37 jC. Considering
the difference in temperature, these values are in good
agreement. A respiratory stimulation of 5 ngatomO/min 1
mg 1 is a very low rate indeed, considering that rat heart
mitochondria can respire in state 3 at over 1000 ngatomO/
min 1 mg 1. This comprises important evidence against
the hypothesis that mitoKATP opening uncouples respira-
tion. This issue is discussed in greater detail in the
companion paper [1].
As expected, the increased respiration due to mitoKATP
opening is too small to perturb Dw very much. Indeed, the
change in Dw is too small to measure, and we estimate that
it is 1–2 mV [63].
11.2. MitoKATP opening increases mitochondrial ROS
production
Adding a mitoKATP opener to cardiomyocytes or per-
fused hearts causes a moderate rise in mitochondrial ROS
production, which is blocked by 5-HD [12,13,150–152].
The ROS production is caused by increased K+ influx into
the matrix, because it can be mimicked by low concen-
trations of valinomycin. As expected, valinomycin-induced
ROS is insensitive to 5-HD [152]. We observe in isolated
mitochondria that mild matrix alkalinization causes in-
creased ROS production. As pointed out in Section 9, netuptake of K+ salts always leads to matrix alkalinization, and
we suggest that this may be the mechanism by which KCOs
induce increased ROS production [64].12. Summary
The mitochondrial potassium cycle is highly regulated to
respond to changing conditions originating from both the
mitochondrion and the cytosol. Under physiological con-
ditions, continual diffusive K+ uptake, accompanied by
anions and water, threatens the integrity of the organelle.
This threat is countered by the K+/H+ antiporter, whose
activity increases in response to increases in matrix volume.
K+ leak into the matrix is exponentially dependent on
membrane potential, and physiological and pathological
decreases in Dw cause matrix contraction. Decreased matrix
volume causes decreased K+/H+ antiport, and a new steady
state balance is achieved at a lower matrix volume. Al-
though this response prevents a total collapse of matrix
volume, this is apparently not sufficient, because the inner
membrane also contains a mitoKATP channel that can
restore matrix volume by adding a parallel conductance
pathway to compensate for the reduced driving force for K+
influx. We consider this volume regulation to be important
for cellular bioenergetics and cardioprotection [1]. The
mitoKATP channel also plays a role in cell signaling by
causing a moderate increase in mitochondrial production of
ROS, which in turn, triggers physiological and cardiopro-
tective signaling pathways [1].Acknowledgements
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